Log In
BCIQ
Print this Print this
 

Dantrium IV, dantrolene sodium (Dantroloen IV)

  Manage Alerts
Collapse Summary General Information
Company SpePharm Holding B.V.
DescriptionInjectable formulation of dantrolene
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHyperthermia
Indication DetailsTreat malignant hyperthermia
Regulatory Designation
PartnerNorgine B.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/24/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today